Missense mutation Thr309Lys in the coagulation factor XII gene in a Spanish family with hereditary angioedema type III.
BACKGROUND
A new type of hereditary angioedema (type III) affecting mainly women with normal C1-inhibitor level and function has been described. Exposition to estrogens is an important precipitating factor. Recently, a missense mutation in the gene of the blood coagulation factor XII (Hageman factor) has been reported in a few families with this type of hereditary angioedema.


OBJECTIVE
To study a patient and her family with recurrent swelling attacks during pregnancy.


METHODS
Complement factors C3 and C4 as well as C1-inhibitor level and function were determined. Genomic DNA was isolated from venous blood samples and screened for mutations in the coagulation factor XII gene.


RESULTS
C3 and C4 levels as well as C1-inhibitor level and function were normal. A missense mutation Thr309Lys was identified in factor XII gene with a heterozygotic pattern. This mutation was also identified in the mother of the patient, her daughter and her son.


CONCLUSIONS
These results support that the mentioned mutation in factor XII gene causes hereditary angioedema type III.
Prieto
A
A
Allergy Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Tornero
P
P
Rubio
M
M
Fernández-Cruz
E
E
Rodriguez-Sainz
C
C
D000328:Adult; D019943:Amino Acid Substitution / Q000235:genetics; D054179:Angioedemas, Hereditary / Q000097:blood / Q000235:genetics*; D005174:Factor XII / Q000235:genetics*; D005260:Female; D006801:Humans; D008239:Lysine / Q000235:genetics; D008297:Male; D020125:Mutation, Missense; D010375:Pedigree; D013912:Threonine / Q000235:genetics
D013912:Threonine; D005174:Factor XII; D008239:Lysine